Abstract
Based on increasing evidence from animal and human studies, vitaminDdeficiency is now regarded as a potential risk factor for Type 2 diabetes mellitus (T2DM). VitaminDis involved in the pathogenesis of pancreaticβ‐cell dysfunction, insulin resistance, and systemic inflammation, conditions that contribute to the development ofT2DM. VitaminDcan affect the progress of this disease directly through the activation of its own receptor, and indirectly via the regulation of calcium homeostasis. Observational studies have revealed the association between vitaminDdeficiency and incidentT2DM. More double‐blind randomized control studies that investigate the effects of vitaminDsupplementation on insulin sensitivity, insulin secretion, and the occurrence ofT2DMare needed.

This publication has 81 references indexed in Scilit: